Ireland Anti-Doping Annual Report 2010

29 Apr 2011

Annual Report of the Anti-Doping Unit of the Irish Sports Council for 2010 / Irish Sports Council (ISC). - Dublin : ISC, 2011

Contents:

- Staff
- Contact Details
- Introduction
- Foreword
- List of Abbreviations
- Visions of the Programme
- Education
- Testing
- Research
- International
- Administration
- Background to the Irish Sport Anti-Doping Programme
- Anti-Doping Committee
- Irish Sport Anti-Doping Disciplinary Panel
Chapter 1 Testing
- Highlights
- Doping Controls
- National Programme- Urine
- National Programme- Blood Testing
- Biological Profiling
- User Pays Programme
- Registered Testing Pool
- Criteria for Registered Testing Pool (RTP)
- Whereabouts Failures System
- Missed Test
- Unsuccessful Attempts
- Sample Collection Personnel (SCP)
Chapter 2 International
- Highlights
- International Olympic Committee (IOC) award
- Scientific literacy in Doping and Anti-Doping
- Association of National Anti-Doping Organisations (ANADO)
- World Anti-Doping Agency (WADA)
- Council of Europe 2
Chapter 3 Education and Research
- Highlights
- Educational Resources
- Educational material sent out to various stakeholders in 2010
- Medicines Information
- Eirpharm
- Real Winner
- Education Seminars
Chapter 4 Administration
- Highlights
- SIMON – Anti-Doping Management System
- Sample Collection Personnel Contract
- Intelligence and Investigations
- ISO certification
- Therapeutic Use Exemptions (TUEs)
- TUE Committee
- Applications for Therapeutic Use Exemptions
Chapter 5 The Year Ahead
- The Year Ahead
- Testing
- Administration
- Education
- Research
- International
- Intelligence
- Appendices
Appendix 1
- Anti-Doping Rule Violations
- Adverse Analytical Findings Forwarded to International Federations for Action
- Retroactive TUEs
- Appendix 2
- Costs of the Programmes 2010

AFLD 2011 FFSCDA vs Respondent M43

28 Apr 2011

Facts
The French Federation for Contact Sport and Associated Disciplines (Fédération Française de Sports de Contact et Disciplines Associées, FFSCDA) charges respondent M43 for a violation of the Anti-Doping Rules. During a K1 event on May 8, 2010, a sample was taken for doping test purposes. The analysis showed the presence of a metabolite of cannabis. Cannabis is a prohibited substance according the World Anti Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
Respondent did mention the occasionally use of cannabis 8 days before the match on the Doping Control Form. But he didn't provide an explanation why it had entered his body.

Decision
1. The sanction is a six months period of ineligibility in which respondent can't take part in competition or sport manifestations organized by the FFSCDA.
2. The decision of September 7, 2010, of the disciplinary committee of the FFSCDA will be modified.
3. The period of ineligibility will be reduced with the period already served by the sanction of September 7, 2010.
4. The results obtained at the event on May 8, 2010, will be cancelled. Medals, points and prizes will be withdrawn.
5. The decision starts on the date of notification.
6. The decision will be published and sent to the parties involved.

AFLD 2011 FFSCDA vs Respondent M42

28 Apr 2011

Facts
The French Federation for Contact Sport and Associated Disciplines (Fédération Française de Sports de Contact et Disciplines Associées, FFSCDA) charges respondent M42 for a violation of the Anti-Doping Rules. During a muaythai event on March 14, 2010, a sample was taken for doping test purposes. The analysis showed the presence of terbutaline. Terbutaline is a prohibited substance according the World Anti Doping Agency (WADA) prohibited list.

History
Respondent didn't provide any information about how the prohibited had entered his body. He did mention that he suffers from allergies on the Doping Control form.

Decision
1. The sanction is a period of ineligibility of nine months in which respondent can't take part in competition or manifestations organized or authorized by the FFSCDA.
2. The decision (six months period of ineligibility) of September 7, 2010, of the disciplinary committee of the FFSCDA will be modified.
3. The period of ineligibility will be reduced by the period already served by the decision of September 7, 2010.
4. All the results obtained at the muaythai event on March 14, 2010, will be cancelled. Medals, points and prizes will be withdrawn.
5. The decision starts on the date of notification.
6. The decision will be published and sent to the parties involved.

NIJB 2011 NIJB Decision Disciplinary Committee 2011003 T

28 Apr 2011

The Netherlands Ice Hockey Association (Nederlandse IJshockey Bond, NIJB) has reported an anti doping rule violation against 2 players after their samples tested positive for the prohibited substance methylhexaneamine (dimethylpentylamine) during two separate anti-doping tests.
Players stated they didn’t know they used a supplement containing a prohibited substance because the label of the supplement did not mention it as ingredient.
The committee accepts the statement of the players as mitigating circumstances. Therefore the players had no intention to enhance their performance. The committee concludes that the players didn’t make further inquiries about the ingredients in the supplement and decides, because of exceptional circumstances, for a period of ineligibility until October 1, 2011.
In additon related to prohibited substance contaminations in supplements, the Disciplinary Committee made an appeal about improving information and prevention addressed to:
- Netherlands Ice Hockey Association
- Ice hockey clubs
- Doping Authority
- The Netherlands Security System Nutritional Supplements Elite Sports
- Players

CAS 2010_A_2229 WADA vs FIVB & Gregory Berrios

28 Apr 2011

CAS 2010/A/2229 WADA v. FIVB & Gregory Berrios

CAS 2010/A/2229 World Anti-Doping Agency (WADA) v. Fédération Internationale de Volleyball (FIVB) & Gregory Berrios

  • Volleyball
  • Doping (sibutramine)
  • Elimination or reduction of the period of ineligibility for specified substances
  • Criteria for the determination of the correct and proportionate sanction by CAS panels
  • Athletes’ responsibility with regard to the intaking of dietary weight loss products or food supplements


1. Article 4.2.2 of the WADA Code seeks to introduce some flexibility when determining a sanction for an athlete that has ingested a Specified Substance; nevertheless, for the elimination or reduction of the period of ineligibility an athlete must establish:

a) how a Specified Substance entered his or her body or came into his or her possession; and

b) that such Specified Substance was not intended to enhance the athlete’s sport performance or mask the use of a performance-enhancing substance.

With respect to the second condition, a panel must be comfortably satisfied by the objective circumstances of the case that the athlete in taking or possessing a Prohibited Substance did not intend to enhance his or her sport performance. An athlete only needs to prove that he/she did not take the specified substance with an intent to enhance sport performance. The athlete does not need to prove that he/she did not take the product with the intent to enhance sport performance. The second condition is thus met when an athlete can produce corroborating evidence in addition to his or her word which establishes to the comfortable satisfaction of a panel that he or she ingested a specified substance unknowingly, e.g. by means of ingesting a contaminated product.

2. In determining, as an international appellate body, the correct and proportionate sanction, CAS panels must also seek to preserve some coherence between the decisions of the different federations in comparable cases in order to preserve the principle of equal treatment of athletes in different sports. In that connection the introduction to the WADA Code expressly states that two of its purposes are to promote equality for athletes worldwide and to ensure harmonization of anti-doping programs. A sanction must further comply with WADA’s objective of proportionate and consistent sanctions for doping offences based on an athlete’s level of fault under the totality of circumstances.

3. In the context of contaminated supplements, CAS panels have highlighted the large number of public warnings and internationally published cases on the risks of mislabeling and/or contamination of nutritional supplements. Since these risks now are generally known or at least foreseeable, all athletes must exercise reasonable care to ensure a nutrition supplement does not contain a banned substance. Although dietary weight loss products may not in the strict sense of the term be deemed a “food supplement”, in essence their use requires the same degree of circumspection and care on the part of an athlete as the use of food supplements. In many sports losing weight can in various manners enhance performance and doing so very fast using natural products is not necessarily easy to achieve, while at the same time it is known that certain substances characterized as stimulants also act as appetite suppressants, meaning that there is a risk that such substances be found in medicaments or health products aimed at accelerated slimming/fast diets. Accordingly, within their responsibilities to take great care to avoid the use of any doping products, athletes in general must be on their guard when considering the ingestion of any weight-losing product, whether in the form of a medicament or a so-called natural dietary product.



In July 2010 the International Volleyball Federation (FIVB) has reported an anti-dopng rule violation against the Athlete Gregory Berrios after his sample tested positive for the prohibited substance Sibutramine. Thereupon the FIVB decided on 4 August 2010 to sanction the Athlete for 3 months because his violation was not intentional.

Hereafter in September 2010 the World Anti-Doping Agency (WADA) appealed the FIVB decision with the Court of Arbitration for Sport (CAS). WADA requested the Panel to set aside the Appealed Decision and to impose a sanction of 1 year.

The Athlete gave a prompt admission and denied the intentional use of the substance. He asserted that analysis of the product Fatlose Slimming Beauty in the NMS Labs had confirmed that it was tainted with Sibutramine.

The Panel assessed and addressed the evidence in this case and determines that:

  • The presence of a prohibited substance has been established in the Athlete's sample and accordingly he committed an anti-doping rule violation.
  • There is corroborating evidence that the contaminants Sibutramine and Phenophthalein were identified in the Fatlose Slimming Beauty product the Athlete had ingested.
  • The Athlete had demonstrated that the violation was not intentional and how the substance had entered his system.
  • Considering the Athlete's degree of negligence the sanction can only be reduced by more than one half of the maximum sanction of 2 years.

Therefore the Court of Arbitration for Sport decides on 28 April 2011:

1.) The appeal filed by the World Anti-Doping Agency on September 15, 2010 is partially upheld.

2.) The decision of the Fédération Internationale de Volleyball of August 4, 2010 is set aside.

3.) Mr. G. Berrios is declared ineligible for a period of one year, commencing on May 27, 2010.

4.) (…).

5.) (…).

6.) All other requests for relief are rejected.

Incongruence in Doping Related Attitudes, Beliefs and Opinions in the Context of Discordant Behavioural Data: In Which Measure Do We Trust?

26 Apr 2011

Incongruence in doping related attitudes, beliefs and opinions in the context of discordant behavioural data: in which measure do we trust? / Andrea Petróczi, Martina Uvacsek, Tamás Nepusz, Nawed Deshmukh, Iltaf Shah, Eugene V. Aidman, James Barker, Miklós Tóth, Declan P. Naughton. - (PLoS ONE 6 (2011) 4 (26 April); e18804) PLoS ONe 6 (2011) 4 (26 April); e18804; p. 1-10)

  • PMID: 21541317
  • PMCID: PMC3082532
  • DOI: 10.1371/journal.pone.0018804


Abstract

Background: Social psychology research on doping and outcome based evaluation of primary anti-doping prevention and intervention programmes have been dominated by self-reports. Having confidence in the validity and reliability of such data is vital.

Methodology/principal findings: The sample of 82 athletes from 30 sports (52.4% female, mean age: 21.48±2.86 years) was split into quasi-experimental groups based on i) self-admitted previous experience with prohibited performance enhancing drugs (PED) and ii) the presence of at least one prohibited PED in hair covering up to 6 months prior to data collection. Participants responded to questionnaires assessing a range of social cognitive determinants of doping via self-reports; and completed a modified version of the Brief Implicit Association Test (BIAT) assessing implicit attitudes to doping relative to the acceptable nutritional supplements (NS). Social projection regarding NS was used as control. PEDs were detected in hair samples from 10 athletes (12% prevalence), none of whom admitted doping use. This group of 'deniers' was characterised by a dissociation between explicit (verbal declarations) and implicit (BIAT) responding, while convergence was observed in the 'clean' athlete group. This dissociation, if replicated, may act as a cognitive marker of the denier group, with promising applications of the combined explicit-implicit cognitive protocol as a proxy in lieu of biochemical detection methods in social science research. Overall, discrepancies in the relationship between declared doping-related opinion and implicit doping attitudes were observed between the groups, with control measures remaining unaffected. Questionnaire responses showed a pattern consistent with self-reported doping use.

Conclusions/significance: Following our preliminary work, this study provides further evidence that both self-reports on behaviour and social cognitive measures could be affected by some form of response bias. This can question the validity of self-reports, with reliability remaining unaffected. Triangulation of various assessment methods is recommended.

An examination of the Sport Drug Control Model with elite Australian athletes

25 Apr 2011

An examination of the Sport Drug Control Model with elite Australian athletes / Daniel F. Gucciardi, Geoffrey Jalleh, Robert J. Donovan. - (Journal of Science and Medicine in Sport 14 (2011) 6 (1 November); p. 469-476)

  • PMID: 21514883
  • DOI: 10.1016/j.jsams.2011.03.009


Abstract

Objective: This study presents an opportunistic examination of the theoretical tenets outlined in the Sport Drug Control Model(1) using questionnaire items from a survey of 643 elite Australian athletes.

Design and method: Items in the questionnaire that related to the concepts in the model were identified and structural equation modelling was employed to test the hypothesised model.

Results: Morality (cheating), benefit appraisal (performance), and threat appraisal (enforcement) evidenced the strongest relationships with attitude to doping, which in turn was positively associated with doping susceptibility. Self-esteem, perceptions of legitimacy and reference group opinions showed small non-significant associations with attitude to doping. The hypothesised model accounted for 30% and 11% of the variance in attitudes to doping and doping susceptibility, respectively.

Conclusion: These present findings provide support for the model even though the questionnaire items were not constructed to specifically measure concepts contained in it. Thus, the model appears useful for understanding influences on doping. Nevertheless, there is a need to further explore individual and social factors that may influence athletes' use of performance enhancing drugs.

CAS 2010_A_2235 UCI vs Tadej Valjavec & Olympic Committee of Slovenia

21 Apr 2011

CAS 2010/A/2235 UCI v/ Tadej Valjavec & Olympic Committee of Slovenia

CAS 2010/A/2235 Union Cycliste Internationale (UCI) v. T. & Olympic Committee of Slovenia (OCS)

  • Cycling
  • Doping (Athlete’s Biological Passport)
  • Burden and Standard of Proof
  • Evaluation of the Experts’ Panel report by the CAS Panel
  • Application of the rules related to the ABP by CAS Panels
  • Violation of EU competition law
  • Disqualification in case of a violation found by reference to the ABP
  • Blood manipulation as aggravating factor for the determination of the ineligibility period
  • Determination of the amount of the fine according to the UCI ADR

1. The burden of proof of establishing an anti-doping violation ex concessis is imposed on UCI. The applicable standard of proof (“comfortable satisfaction”) is a lower standard than the criminal standard (beyond reasonable doubt) but a higher standard than the civil standard (balance of probabilities). Application of the standard to any particular set of facts may produce different results depending on those facts. But the standard itself is uniform, irrespective of the facts. It demands an exercise of judgment.

2. Any Tribunal faced with a conflict of expert evidence must approach the evidence with care and self-awareness of its own lack of expertise in the area under examination. Nonetheless, notwithstanding these caveats, it cannot abdicate its adjudicative role. A CAS panel shall apply the standard of proof as an appellate body to determine whether the expert panel’s evaluation is soundly based in primary facts, and whether the expert panel’s consequent appreciation of the conclusion be derived from those facts is equally sound. It will necessarily take into account, inter alia, the impression made on it by the expert witnesses in terms of their standing, experience, and cogency of their evidence together with that evidence’ s consistency with any published research.

3. A CAS panel is not called to adjudicate on whether some other or better system of longitudinal profiling could be created. WADA has approved the use of ABP and this has been codified in the current UCI rules. A CAS panel must respect and apply the rules as they are and not as they might have been or might become.

4. According to the jurisprudence of the European Court of Justice, anti-doping rules and sanctions “are justified by a legitimate objective” and any related limitation to the athletes’ economic freedom “is inherent in the organisation and proper conduct of competitive sport and its very purpose is to ensure healthy rivalry between athletes”. While it is true that restrictions imposed by anti-doping rules and sanctions “must be limited to what is necessary to ensure the proper conduct of competitive sport” and, thus, must be proportionate, the Athlete has to adduce evidence to establish that the anti-doping rules and sanctions at issue are disproportionate and, as a consequence, to establish a violation of Article 101 of the Treaty on the Functioning of the European Union.

5. Although the provisions as to disqualification are expressly made applicable to violations consisting of use of a prohibited method, they are not easy to apply where the proof of such violation is to be found by reference to the ABP. The provisions are geared to the situation where the violation is an occurrence rather than a process, most obviously where the violation is the presence of a prohibited substance. Article 289 of the UCI ADR provides in its title for disqualification of results in events during which an anti-doping violation occurs. Even though the text enlarges the title to embrace violations occurring ‘‘in connection with an event’’ it is not easy in ABP cases to identify in connection with which events the Athlete’s doping violation occurred. Therefore, as Article 313 of the UCI ADR provides in its title for disqualification of results in competitions subsequent to anti-doping rule violation but is applicable only when article 289 of the UCI ADR is not, this article more easily fits ABP cases.

6. A submission that blood manipulation constitutes an aggravating factor and that a minimum three-year ban should be imposed upon the Athlete has no foundation in the UCI ADR which does not differentiate between various forms of first offence or suggest that blood manipulation attracts ratione materiae a higher sanction than the presence of a prohibited substance.

7. Article 326 of the UCI ADR provides a formula for computation of the fine with a proviso allowing for a reduction of up to a half for the financial situation of the licence holder concerned. Reduction from the figure so calculated is available under the same article where the Athlete’s financial situation justifies it. It requires a CAS panel to consider the particular facts before it.


In May 2010 the UCI reported an anti-doping rule violation against the Slovene cyclist Tadej Valjavec after an UCI Expert Panel concluded unanimously, in December 2009 in their Expert Opinion, that the Athlete’s hematological profile “highly likely” showed that he used a prohibited substance or a prohibited method: the use of EPO or Blood doping.

This conclusion of the UCI Expert Panel is based on assessment of blood samples, collected in the period from 21 March 2008 until 29 August 2009 reported in the Athlete’s Biological Passport (ABP).

Previously the Athlete submitted his explanations for the abnormal findings in his ABP to the UCI which were rejected by the Expert Panel in their second Experts Opinion Report submitted in April 2010.

However on 28 July 2010 the Senate of the National Anti-Doping Commission of the Olympic Committe of Slovenia (OCS) decided that the Athlete had not committed an anti-doping rule violation nor to impose a sanction on the Athlete.

Hereafter in September 2010 the UCI appealed the Slovenian Decision with the Court of Arbitration for Sport (CAS). The UCI requested the Panel to set aside the Appealed Decision and to impose a fine and a sanction of minimum 3 years on the Athlete.

The UCI contended having established that the Athlete had committed an ADRV based on the abnormalities detected in the Athlete’s haematological profile resulting from his ABP.

The Athlete disputed the reliability of the ABP. He asserted, supported by expert witnesses that no ADRV has taken place and no sanction is to be imposed on him

Following assessment of the submissions, arguments and evidence the Panel determines:

  • (i) there were no defects in the process of analysis or breaches in the chain of custody such as would make the results of the critical tests unreliable;
  • (ii) those tests on 19 April and 29 August 2009 revealed abnormalities in the context of the Athlete’s ABP such as to excite the need for explanation;
  • (iii) the explanations given were as scrutinized by the UCI’s experts whose testimony, where their evidence conflicted with the evidence of the Athlete’s experts, the CAS Panel preferred both because of their (for the most part) greater experience and expertise, and because of the weight of published literature which supported it;
  • (iv) in any event the factual premise for the Athlete’s explanations depended in substantial measure on his say- so uncorroborated by independent testimony, and the CAS Panel was disinclined to accept it where it was manifestly improbable, e.g. the failure to report alarming black stools in April 2009;
  • (v) the pattern of values under scrutiny was entirely consistent with blood manipulation, not least, but not only, because of the degree of abnormality;
  • (vi) the coincidence of the blood manipulation asserted by UCI with the Athlete’s racing calendar was striking;
  • (vii) no discrimination against him nor violation of EU competition law was proven by the Athlete.

Therefore the Court of Arbitration for Sport decides on 21 April 2011:

1.) The appeal filed by UCI against the decision issued on 28 July 2010 by the Senate of the National Anti-Doping Commission of the OCS is upheld.

2.) The decision issued on 28 July 2010 by the Senate of the National Anti-Doping Commission of the OCS is annulled in its entirety.

3.) Tadej Valjavec is found guilty of an anti-doping rule violation and is declared ineligible for a period of two years running from 20 January 2011.

4.) Tadej Valjavec’s results obtained during the period from 19 April 2009 to end of September 2009 and from 20 January 2011 until the date of notification of this award, including his event medals, his points and prizes are forfeited.

5.) Tadej Valjavec shall pay to UCI a fine of EUR 52,500, in accordance with article 326 1.a) of the UCI ADR.

6.) (…).

7.) (…).

8.) All other motions or prayers for relief are dismissed.

ANAD Comisia de Audiere 2011_11 ANAD vs Silviu Budileanu

20 Apr 2011

In March 2011 the Agenţia Naţională Anti-Doping (ANAD), the National Anti-Doping Agency of Romania, has reported an anti-doping rule violation against the Athlete Silviu Budileanu after his sample tested positive for the prohibited substance cannabis.
After notification the Athlete filed a statement in his defence and did not attend the hearing of the ANAD Hearing Commission. The Athlete admitted the use of cannabis and did not request the B sample analysis.
Due to this is the Athlete’s second violation the ANAD Hearing Commission decides to impose a 2 year period of ineligibility on the Athlete, starting on the date of the decision.

Swiss Federal Court 4A_640_2010 Edward Eranosian vs WADA, FIFA & CFA

18 Apr 2011

Related case:
CAS 2009/A/1817 & CAS 2009/A/1844 WADA & FIFA vs Cyprus Football Association (CFA), Carlos Marques, Leonel Medeiros, Angelos Efthymiou, Yiannis Sfakianakis, Dmytro Mykhailenko, Samir Bengeloun, Bernardo Vasconcelos & Edward Eranosian
October 26, 2010

In November 2008 the Cyprus Football Association (CFA) has reported two separate anti-doping rule violations against two football players of the Cyprian APOP Kinyras football team after their A and B samples, provided in October and November 2008, tested positive for the prohibited substance oxymesterone.

After an investigation the CFA Judicial Committee decided on 2 April 2009 to impose a 1 year period of ineligibility on the two Cyprian football players.
The CFA investigation showed that the Bulgarian football trainer Mr. Edward Eranosian of APOP Kinyras provided the pills to the football players. Due to his substantial assistance in the investigation a 2 year period of ineligibility was imposed on him instead of a 4 year period.

WADA appealed the CFA decision of 2 April 2009 with the Court of Arbitration for Sport (CAS).
On 26 October 2010, the CAS Panel decided to uphold the WADA appeal and to impose a 4 year period of ineligibility on the trainer Mr. Edward Eranosian (CAS 2009/A/1817 & CAS 2009/A/1844) .

Hereafter the Mr. Eranosian appealed the CAS decision of 26 October 2010 to the Swiss Federal Court.
The Swiss Federal Court decides to reject the appeal on 18 April 2011 to the extent that matter is capable of appeal.

The Swiss Federal Court’s opinion in this case:

The issue was that, as a professional trainer registered with the Cyprus Football Association, the trainer had undertaken to comply with the anti-doping provisions of the Cyprus Football Association as well as with the FIFA Statutes because the Cyprus federation statutes contained an undertaking to ensure that the members comply with FIFA regulations and statutes, which require compliance with anti-doping rules. It thus created the basis for CAS’ exercise of jurisdiction pursuant to articles 62 and 63 of the FIFA Statutes.

Despite a well-reasoned argument that the reference to the Cyprus federation statutes was merely with regard to the substantive anti-doping rules of FIFA and was not intended to create CAS jurisdiction by reference to articles 62 and 63 of the FIFA Statutes, the Court rejected it. Instead, it emphasized the importance of CAS jurisdiction, albeit by what were at times somewhat thin references, because of the importance of ensuring that doping is not tolerated.

As will be clear from the foregoing, the opinion will be of interest to readers who practice sports arbitration. The decision also shows that the Swiss Supreme Court is ready to broadly interpret CAS jurisdiction when there are public interest issues involved.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin